{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T02:24:10Z","timestamp":1783563850515,"version":"3.55.0"},"reference-count":21,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Generalized prurigo nodularis (GPN) is a debilitating, inflammatory skin disease characterized by chronic pruritus, signs of prolonged scratching, and multiple pruriginous papules and nodules. Recent studies identified several forms of GPN as a clinical phenotype of adult atopic dermatitis (AD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of the study was to evaluate the effectiveness of dupilumab (D) in adults affected by persistent AD showing a clinical feature of GPN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study was performed on adult patients affected with GPN clinical variant of AD, treated with D from July 2018 to March 2019. Atopic dermatitis severity was evaluated using the Eczema Area and Severity Index, visual analog scales ranging from 0 to 10 for pruritus, and Dermatology Life Quality Index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Ninety AD patients (52 males [57.7%]; mean age = 44.6 years; range = 18\u201366 years) were treated with D. In 9 (10.0%) of 90 cases, GPN pattern was observed. A significant improvement in Eczema Area and Severity Index, Dermatology Life Quality Index, and pruritus visual analog scale score was observed after treatment with D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Generalized prurigo nodularis is currently considered to be a rather common clinical pattern of adult AD. Dupilumab can be an efficacious treatment of this condition, especially in cases where history of atopy is recorded and conventional treatments are ineffective.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/der.0000000000000517","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T22:06:16Z","timestamp":1568325976000},"page":"81-84","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":60,"title":["Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Phenotype of Adult Atopic Dermatitis"],"prefix":"10.1177","volume":"31","author":[{"given":"Maddalena","family":"Napolitano","sequence":"first","affiliation":[{"name":"From the, *Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Fabbrocini","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Scalvenzi","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Paul","family":"Nistic\u00f2","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University Magna Graecia of Catanzaro, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Dastoli","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University Magna Graecia of Catanzaro, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cataldo","family":"Patruno","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, University Magna Graecia of Catanzaro, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,2,1]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1001\/jamadermatol.2018.3912","article-title":"Dupilumab treatment for generalized prurigo nodularis","volume":"155","author":"Beck KM","year":"2019","unstructured":"Beck KM, , Yang EJ, , Sekhon S, et al. Dupilumab treatment for generalized prurigo nodularis. JAMA Dermatol, 2019; 155:118\u2013120.","journal-title":"JAMA Dermatol"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.09.020"},{"key":"e_1_3_1_4_2","first-page":"221","article-title":"Prurigo nodularis: picking the right treatment","volume":"64","author":"Saco M","year":"2015","unstructured":"Saco M, , Cohen G. Prurigo nodularis: picking the right treatment. J Fam Pract, 2015; 64:221\u2013226.","journal-title":"J Fam Pract"},{"key":"e_1_3_1_5_2","first-page":"509","article-title":"The diagnosis and graded therapy of atopic dermatitis","volume":"111","author":"Werfel T","year":"2014","unstructured":"Werfel T, , Schwerk N, , Hansen G, et al. The diagnosis and graded therapy of atopic dermatitis. Dtsch Arztebl Int, 2014; 111:509\u2013520.","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0138"},{"key":"e_1_3_1_7_2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4103\/0366-6999.178960","article-title":"Clinical features of adult\/adolescent atopic dermatitis and Chinese criteria for atopic dermatitis","volume":"129","author":"Liu P","year":"2016","unstructured":"Liu P, , Zhao Y, , Mu ZL, et al. Clinical features of adult\/adolescent atopic dermatitis and Chinese criteria for atopic dermatitis. Chin Med J (Engl), 2016; 129:757\u2013762.","journal-title":"Chin Med J (Engl)"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555924447"},{"key":"e_1_3_1_9_2","first-page":"383","article-title":"Working Party's Diagnostic Criteria for Atopic Dermatitis","volume":"131","author":"Williams HC","year":"1994","unstructured":"Williams HC, , Burney PG, , Hay RJ, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol, 1994; 131:383\u2013396.","journal-title":"I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol"},{"key":"e_1_3_1_10_2","first-page":"397","article-title":"Working Party's Diagnostic Criteria for Atopic Dermatitis","volume":"131","author":"Williams HC","year":"1994","unstructured":"Williams HC, , Burney PG, , Strachan D, et al. The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol, 1994; 131:397\u2013405.","journal-title":"II. Observer variation of clinical diagnosis and signs of atopic dermatitis. Br J Dermatol"},{"key":"e_1_3_1_11_2","first-page":"133","article-title":"Diagnosis and management of moderate to severe adult atopic dermatitis: a consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA)","volume":"153","author":"Calzavara Pinton P","year":"2018","unstructured":"Calzavara Pinton P, , Cristaudo A, , Foti C, et al. Diagnosis and management of moderate to severe adult atopic dermatitis: a consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA). G Ital Dermatol Venereol, 2018; 153:133\u2013145.","journal-title":"G Ital Dermatol Venereol"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12365"},{"key":"e_1_3_1_13_2","first-page":"20","article-title":"Dramatic improvement of generalized prurigo nodularis with dupilumab","author":"Calugareanu A","year":"2019","unstructured":"Calugareanu A, , Jachiet M, , Lepelletier C, et al. Dramatic improvement of generalized prurigo nodularis with dupilumab. J Eur Acad Dermatol Venereol, 2019; 20.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamadermatol.2018.3906","article-title":"Reduced itch associated with dupilumab treatment in 4 patients with prurigo nodularis","volume":"155","author":"Mollanazar NK","year":"2019","unstructured":"Mollanazar NK, , Elgash M, , Weaver L, et al. Reduced itch associated with dupilumab treatment in 4 patients with prurigo nodularis. JAMA Dermatol, 2019; 155:121\u2013122.","journal-title":"JAMA Dermatol"},{"key":"e_1_3_1_15_2","first-page":"1337","article-title":"Harmonising Outcome Measures for Atopic Dermatitis (HOME) Initiative","volume":"132","author":"Schmitt J","year":"2013","unstructured":"Schmitt J, , Langan S, , Deckert S, et al. Harmonising Outcome Measures for Atopic Dermatitis (HOME) Initiative. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol, 2013; 132:1337\u20131347.","journal-title":"Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. J Allergy Clin Immunol"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/bjd.15905","article-title":"Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial","volume":"178","author":"Tsianakas A","year":"2018","unstructured":"Tsianakas A, , Luger TA, , Radin A. Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial. Br J Dermatol, 2018; 178:406\u2013414.","journal-title":"Br J Dermatol"},{"key":"e_1_3_1_17_2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.5124\/jkma.2014.57.3.212","article-title":"Diagnosis for atopic dermatitis","volume":"57","author":"Lee SC.","year":"2014","unstructured":"Lee SC. Diagnosis for atopic dermatitis. J Korean Med Assoc, 2014; 57:212\u2013217.","journal-title":"J Korean Med Assoc"},{"key":"e_1_3_1_18_2","first-page":"443","article-title":"Italian Adult Atopic Dermatitis Study Group","volume":"309","author":"Megna M","year":"2017","unstructured":"Megna M, , Patruno C, , Balato A, et al. Italian Adult Atopic Dermatitis Study Group. An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease. Arch Dermatol Res, 2017; 309:443\u2013452.","journal-title":"An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease. Arch Dermatol Res"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2012.01740.x"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2004.02360.x"},{"key":"e_1_3_1_21_2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/exd.13514","article-title":"Atopic dermatitis in diverse racial and ethnic groups - variations in epidemiology, genetics, clinical presentation and treatment","volume":"27","author":"Kaufman BP","year":"2018","unstructured":"Kaufman BP, , Guttman-Yassky E, , Alexis AF. Atopic dermatitis in diverse racial and ethnic groups - variations in epidemiology, genetics, clinical presentation and treatment. Exp Dermatol, 2018; 27:340\u2013357.","journal-title":"Exp Dermatol"},{"key":"e_1_3_1_22_2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1365-2133.2011.10498.x","article-title":"Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis","volume":"165","author":"Fukushi S","year":"2011","unstructured":"Fukushi S, , Yamasaki K, , Aiba S. Nuclear localization of activated STAT6 and STAT3 in epidermis of prurigo nodularis. Br J Dermatol, 2011; 165:990\u2013996.","journal-title":"Br J Dermatol"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000517","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1097\/DER.0000000000000517","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1097\/DER.0000000000000517","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:05:02Z","timestamp":1777399502000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2,1]]}},"alternative-id":["10.1097\/DER.0000000000000517"],"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000517","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,1]]}}}